Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design

A new clinical trial involving patients with multiple myeloma is making use of a platform study design in order to test multiple different therapies for the hematologic malignancy. The MyDRUG platform trial will be run by the Multiple Myeloma Research Foundation (MMRF) to simultaneously investigate multiple targeted treatments.